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ABSTRACT Control of oxidative metabolism was studied using 13C NMR spectroscopy to detect rate-limiting steps in 13C
labeling of glutamate. 13C NMR spectra were acquired every 1 or 2 min from isolated rabbit hearts perfused with either 2.5
mM [2-13C]acetate or 2.5 mM [2-l 3C]butyrate with or without KCI arrest. Tricarboxylic acid cycle flux (VTcA) and the exchange
rate between a-ketoglutarate and glutamate (F1) were determined by least-square fitting of a kinetic model to NMR data.
Rates were compared to measured kinetics of the cardiac glutamate-oxaloacetate transaminase (GOT). Despite similar
oxygen use, hearts oxidizing butyrate instead of acetate showed delayed incorporation of 13C label into glutamate and lower
VTCA, because of the influence of ,B-oxidation: butyrate = 7.1 ± 0.2 ,umol/min/g dry wt; acetate = 10.1 + 0.2; butyrate +
KCI = 1.8 + 0.1; acetate + KCI = 3.1 ± 0.1 (mean ± SD). F1 ranged from a low of 4.4 ± 1.0 ,umol/min/g (butyrate + KCI)
to 9.3 ± 0.6 (acetate), at least 20-fold slower than GOT flux, and proved to be rate limiting for isotope turnover in the glutamate
pool. Therefore, dynamic 13C NMR observations were sensitive not only to TCA cycle flux but also to the interconversion
between TCA cycle intermediates and glutamate.
INTRODUCTION
13C NMR spectroscopy of tissue metabolism has been ap-
plied to numerous living systems and has generated wide-
spread interest for application to laboratory investigations of
intact organs and in vivo animal models. An important early
contribution was the kinetic modeling of tricarboxylic acid
(TCA) cycle flux via 13C labeling within glutamate as
detected in in vitro spectra of tissue extracts from different
time points (Chance et al., 1983). Such work is based
largely on previously described patterns of 14C incorpora-
tion in metabolites that were determined via traditional,
destructive biochemical methods (Kelleher, 1985; Strisower
et al., 1952; Weinman et al., 1957). However, the chemical
specificity of NMR spectroscopy allows identification of
labeled metabolites to be performed on intact tissues. Thus,
an attractive feature of using 13C NMR spectroscopy for
physiological applications remains the potential for the ki-
netic analysis of dynamic changes in 13C spectra obtained
over time from functioning, intact hearts and in vivo
preparations (Lewandowski, 1992b; Weiss et al., 1992;
Robitaille et al., 1993a).
Dynamic changes in 13C spectra from intact hearts have
been related to different workloads without changes in
high-resolution, multiplet structures in spectra from extracts
of the same hearts (Lewandowski, 1992b). Such data are
dependent on turnover of label within the TCA cycle, and it
is tempting to offer such spectra as a means of evaluating
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TCA cycle flux. However, simply equating isotope turnover
to TCA cycle flux does not take advantage of the power and
utility of 13C NMR to provide new information not other-
wise available from intact tissues using methodologies such
as oxygen consumption rates or radiolabeled CO2 release.
Instead, 13C NMR methods can be used to discern other
rate-limiting processes through appropriate applications of
kinetic modeling schemes.
Because of the low concentrations of TCA cycle inter-
mediates involved in the recycling of label within the glu-
tamate pool, metabolic events more subtle than the simple
labeling of glutamate are seldom detected and remain gen-
erally overlooked. Because no less than 90% of the gluta-
mate is located in the cytosol (LaNoue et al., 1970) and the
labeling of glutamate occurs through isotope exchange with
a-ketoglutarate, glutamate labeling remains an indirect in-
dicator of 13C labeling of TCA cycle intermediates. How-
ever, the influence of the isotope exchange rate between
glutamate and a-ketoglutarate on isotope turnover within
the glutamate pool is not well characterized.
Fundamental to such 13C NMR studies has been the
assumption that the TCA cycle intermediate, a-ketoglut-
arate, is in rapid exchange with glutamate, according to
earlier work showing chemical equilibrium across the glu-
tamate-oxaloacetate transaminase (GOT) in the heart
(Randle et al., 1970). Until now, this assumption has not
been tested in intact tissues, although isolated enzyme mea-
surements of liver GOT, the enzyme that catalyzes this
reaction, do show that the enzyme has a large Vmax value
(Fahien and Strmecki, 1969a,b). However, less well estab-
lished is whether metabolite transport across the mitochon-
drial membrane is negligible in studies of intact tissues. The
intra- and extra-mitochondrial glutamate pools are deter-
mined by transport of metabolites that is influenced by
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mitochondrial membrane potential and the redox-dependent
malate-aspartate shuttle (Safer, 1975). Thus, the evolution
of presteady state 13C NMR spectra is unlikely to be deter-
mined solely by TCA cycle activity and may, in fact, be
dominated by metabolic communication between subcellu-
lar compartments. Therefore, this study was aimed at de-
veloping dynamic methods of 13C NMR detection and ki-
netic data analysis to quantify such rate-limiting events
within intact hearts.
Experiments were designed to monitor 13C enrichment
rates and isotope turnover within the glutamate pool of
isolated rabbit hearts. Isotope kinetics were evaluated under
conditions of 1) direct entry and rapid turnover of label in
the TCA cycle via 13C-enriched acetate and 2) regulated
entry of label in the TCA cycle via (3-oxidation of 13C-
enriched butyrate (Lewandowski et al., 1991a). Dynamic
13C NMR was used to assess the influences of physiological
demand and metabolic flux on the turnover of 13C in intact
rabbit hearts. Studies were aimed at testing the relative
contributions of TCA cycle flux and interconversion of
labeled a-ketoglutarate and glutamate to the pre-steady-
state evolution of 13C enrichment within the NMR-detect-
able glutamate pool. 13C enrichment kinetics was evaluated
during manipulation of TCA cycle flux secondary to either
activity through 13-oxidation (acetate versus butyrate) or
altered metabolic demand (mechanical work versus basal
metabolic state). Additional measurements of cardiac
transaminase rates allowed direct comparison to the kinetic
NMR data of isotope exchange rates in intact hearts. The
findings indicate that kinetic analysis of 13C NMR data is
sensitive to both TCA cycle flux and the interconversion of
metabolite pools across the mitochondrial membrane, which
can be rate limiting.
MATERIALS AND METHODS
Isolated heart model
Hearts were excised from Dutch belted rabbits (550-700g) that were
heparinized (1000 units) and anesthetized with sodium pentobarbital (100
mg/kg intraperitoneal injection). Immediately upon excision, the heart was
immersed in a solution containing 20 mM KCI and 120 mM NaCl for
cardioplegia at 0°C. The aorta was cannulated for retrograde perfusion at
100 cm hydrostatic pressure with a modified Krebs-Henseleit buffer equil-
ibrated with 95% 02-5% CO2 at 370C. The buffer contained (in mM): NaCl
116, KCI 4, CaCl2 1.5, MgSO4 1.2, NaH2PO4 1.2, and NaHCO3 25. During
preparation, hearts were perfused with buffer containing 5 mM glucose. A
latex balloon was placed in the left ventricle and connected to a pressure
transducer line and physiograph (Gould, Inc., Cleveland, OH). The balloon
was inflated with water to create a diastolic pressure of 5-10 mmHg. Left
ventricular developed pressure (LVDP) and heart rate (HR) were contin-
ually measured and recorded with the intraventricular balloon. Rate-pres-
sure product (RPp = HR X LVDP) was used as an index of mechanical
work. Myocardial oxygen consumption (MVO2) was calculated from the
difference in 02 content of perfusion medium in the supply line and
coronary effluent collected from the pulmonary artery (Neely et al., 1967).
Temperature of the hearts was continuously maintained at 37°C by warm
Experimental protocol
Four experimental groups were comprised of hearts perfused with: 1) 2.5
mM acetate (n = 5); 2) 2.5 mM butyrate to introduce (3-oxidation (n = 6);
3) acetate + 20 mM KCI to achieve basal metabolic state (n = 5);
and 4) 2.5 mM butyrate + 20 mM KCI (n = 5). Additional experiments
were done with hearts perfused with [2,4-13C]butyrate at normal workload
to eliminate the partial labeling of acetyl-CoA from (3-oxidation (n = 2).
At the start of each protocol, hearts were perfused with either unlabeled
acetate or butyrate for 10 min to reach metabolic equilibrium. At this time,
a natural abundance 13C spectrum was acquired. The substrate supply was
then switched to the corresponding 13C-labeled substrate: either [2-13C]ac-
etate or [2-13C]butyrate (Isotec, Inc., Miamisburg, OH), with or without
KCI. Sequential 13C spectra were then acquired every 1.25 (acetate) or 2.5
(butyrate) min until steady-state enrichment was reached. After each per-
fusion, hearts were freeze-clamped for biochemical assays and high reso-
lution 13C NMR of tissue extracts.
It is necessary to point out that neither acetate nor butyrate is a
physiological substrate for the in vivo heart. However, these two substrates
present the simplest scenario for studies that aim at the characterization of
rate-limiting steps in isotope kinetics, whereas more physiological sub-
strates, such as long-chain fatty acids, would introduce new rate-limiting
steps in the incorporation of label into the glutamate pool, i.e., activation
and transport of long-chain fatty acids into the mitochondria. Therefore, the
choice of acetate and butyrate as the sole exogenous substrate offers a
simple, well-controlled model that serves the purposes of this study well.
Dynamic 13C NMR measurements
Perfused hearts were placed within a sample tube in a 20-mm broad-band
NMR probe (Bruker Instruments, Billerica, MA), which was situated in a
vertical-bore superconducting NMR magnet operating at a field strength of
9.4 T (Bruker Instruments). NMR data were collected with a Bruker 400
MSL NMR spectrometer. Before each experiment, the magnetic field
homogeneity was optimized by shimming on the proton signal of water in
the sample to a line width of 20-30 Hz.
13C NMR spectra from intact hearts were acquired at 101 MHz with a
450 pulse angle and 2-s recycle time over 24 to 64 scans (1- to 2.5-min
period). Bilevel broad-band decoupling at 0.5 W (1.8 s) and 7.0 W (17 Ps)
was applied to eliminate carbon-proton coupling and to induce nuclear
Overhauser enhancement (NOE) without sample heating. The free induc-
tion decay (FID) was acquired with an 8K data set. Changes in relative
signal intensities due to nuclear Overhauser enhancement or the relaxation
effect were negligible under these pulsing conditions (Lewandowski and
Hulbert, 1991; Lewandowski et al., 1991b; Malloy et al., 1988). Natural
abundance 13C signal was digitally subtracted, and the raw signal was
processed by exponential filtering with a line broadening of 20 Hz to
enhance the signal-to-noise ratio before being converted into the frequency
domain by Fourier transformation. Peak assignments were referenced to
the known resonance of the exogenous, 13C-enriched substrate (2-carbon of
acetate at 24.1 ppm, 2-carbon of butyrate at 40.2 ppm) and the well-
documented glutamate signals (Bailey et al., 1981; Chance et al., 1983).
NMR signal intensities were determined for all spectra by curve-fitting
each resonance peak with a Lorentzian curve and integrating the area under
the fitted curve with NMR-dedicated software (NMR1, Tripos Associates,
Inc., St. Louis, MO).
Kinetic analysis of GOT
The exchange of isotope from the TCA cycle to glutamate occurs through
a transamination reaction that also involves oxaloacetate and aspartate.
Two isoforms of GOT exist, mitochondrial and cytosolic (Michuda and
Martinez-Carrion, 1970). However, the reaction rate of this GOT has not
been defined for rabbit heart. The kinetic parameters of both GOTs were
measured in this study as described below.
Isolated rabbit hearts were perfused with MSEE buffer (225 mM man-
air flow controlled at the NMR system console.
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at 0°C and pH 7.0). From homogenized tissue, the cytosolic and mitochon-
drial fractions were separated by differential centrifugation (Berkich et al.,
1991). Measurement of protein content per milliliter in the total homoge-
nate and in the supernatant yielded the percentage of supernatant (cytoso-
lic) present in the total rabbit heart homogenate. Measurements of citrate
synthase activity (Idell-Wenger et al., 1978) in the total homogenate and
the isolated mitochondrial fraction allowed determination of the percentage
of mitochondrial protein in the total homogenate. The fraction of mito-
chondrial protein was determined to be 31%.
The specific activity of cytosolic GOT for synthesis of glutamate and
oxaloacetate was measured in 150 mM KCI, 25 mM MOPS, 10 mM Tris,
5 mM NaCl, 0.15 mM NADH, and 2 U/ml malate dehydrogenase (MDH)
at pH 7.2. Enzymatic activity in the forward and reverse directions was
determined by the change in absorbance at 340 nm or 280 nm, respectively.
Mitochondrial GOT activity was determined at pH 7.7 to mimic the
mitochondrial matrix (Chacon et al., 1994). Aliquots of mitochondria were
pre-incubated with 0.05% Triton X100 to permeabilize the mitochondria.
Vmax for GOT was determined in the presence of 10 mM aspartate and
a-ketoglutarate. The Km values for both a-ketoglutarate and aspartate
concentration were determined in the presence of an excess of one reactant
(10 mM) while varying the concentration of the other. The Km for gluta-
mate was determined by varying glutamate concentration with 2 mM
oxaloacetate in the absence of NADH and MDH (Fahien and Strmecki,
1969a).
Tissue chemistry
Acid extracts were obtained from ventricular muscle of hearts perfused in
the magnet as previously described (Lewandowski, 1992a,b). Glutamate,
a-ketoglutarate, and aspartate contents in myocardium were determined
by spectrophotometric or fluorometric techniques (Bergmeyer, 1974;
Williamson and Corkey, 1969). Extracts were then lyophilized and recon-
stituted in 0.5 ml deuterium oxide (D20). High-resolution 13C spectra of
reconstituted extract material were obtained.
High-resolution 13C NMR
High-resolution 13C NMR spectra of tissue extracts reconstituted in 0.5 ml
D20 were obtained with a 5-mm 13C probe (Bruker Instruments, Billerica,
MA). In vitro 13C spectra were collected over 3000 or 6000 scans (450
pulse, 1.8-s recycle time) with broad-band proton decoupling. Samples
were spun (20 Hz) to average out field inhomogeneities. The free induction
decay (FID) was acquired with a 32K data set and zero filled to 64K to
improve spectral resolution. The signal was processed by 2 Hz exponential
filtering followed by Fourier transformation. The multiplet structure of the
glutamate carbon signal allowed the fraction of 2-carbon-labeled acetyl-
CoA entering the TCA cycle (F0) and the ratio of anaplerotic flux to citrate
synthase (y) to be calculated (Malloy et al., 1987, 1988). The amount of
glutamate labeled at the 4-carbon position was determined by comparing
the signal intensity from the glutamate 4-carbon resonance peak within
each 13C spectrum to a standard 100 mM (1.1 mM 13C natural abundance)
solution of glutamate. The total 13C-labeled glutamate at the 4-carbon
position was then divided by the total tissue concentration of glutamate
from enzymatic assay to obtain the fractional enrichment of glutamate at
the 4-carbon position (Lewandowski, 1992a,b).
Kinetic model and analysis
Over the course of perfusion with 13C-enriched substrate, incorporation of
label into the glutamate pool was detected by 13C NMR. The appearance
of resonance peaks that correspond to 13C enrichment at specific carbon
positions within the glutamate pool have been described in detail by others
(Chance et al., 1983; Lewandowski and Johnston, 1990; Malloy et al.,
1988). Detection of the 13C NMR signal from glutamate is based on the
relatively high concentration of intracellular glutamate that is in constant
exchange with the TCA cycle via a-ketoglutarate. Initial incorporation of
label from the oxidation of either [2-13C]acetate or butyrate into the
glutamate pool occurs at the 4-carbon position. The recycling of the label
places 13C at either the 2- or 3-carbon of glutamate. Labeling is equally
probable at the 2- or 3-carbon of glutamate because of the symmetry of the
succinate molecule. Although some investigators have reported asymmet-
ric labeling of malate in various mammalian tissues perfused with 13C-
labeled propionate (Sherry et al., 1994), this phenomenon has not been
observed in NMR experiments involving functioning tissues oxidizing
substrates that enter the TCA cycle via acetyl-CoA (Lewandowski, 1992b;
Weiss et al., 1992). Because glutamate is largely located in cytosol,
whereas the TCA cycle occurs in mitochondria, 13C-enriched a-ketoglu-
tarate is transported out of mitochondria before chemical exchange occurs
between a-ketoglutarate and glutamate (Fig. 1 A) (LaNoue et al., 1973).
Analysis of metabolic activity was based on observations of pre-steady-
state 13C NMR spectra of glutamate reflecting the dynamic labeling pattern
described above. A kinetic model was developed to investigate 13C label-
ing within key metabolic compartments. The model was derived from the
simplified metabolic compartment model that includes key, rate-limiting
tricarboxylate pools as well as the major contributing amino acid pools,
glutamate and aspartate (Fig. 1 B). This simplification was justified by
comparing the simulated results with that of a more comprehensive model
that also includes a succinate and fumarate pool. Analysis is determined at
steady-state flux and with constant intermediate pool sizes. Because of
the symmetry in 2- and 3-carbon labeling, the model only considers the
labeling of 2-carbon while regarding the labeling of 3-carbon as equal to
that of 2-carbon. Citrate, a-ketoglutarate, and glutamate pools are further
divided into 2 subcompartments to represent 13C labeling at the 2- and
4-carbon positions of each intermediate. Effects of substrate utilization and
anaplerosis are also accounted for by incorporating data measured from
high-resolution 13C NMR as parameters in the model. Incorporation of
unlabeled intermediate through anaplerosis was considered to enter the
TCA cycle at malate while efflux of carbon mass (cataplerosis) occurred
through the malic enzyme (Kornberg, 1966; Peuhkurinen, 1984; Russell
and Taegtmeyer, 1991). Kinetic equations describing pre-steady-state la-
beling of each compartment were derived by the principle of mass con-
servation. This kinetic model, comprising nine differential equations, is
presented in further detail in the Appendix.
With a single 9 X 1 vector q to represent the fractional enrichment of
each compartment as a function of time, the model can then be described
in matrix form as
d
q = MTCA q + UAcetyl-CoA
where MTCA is a 9 X 9 matrix characteristic of the TCA cycle, its elements
are dependent on the TCA cycle flux (VTCA), the interconversion rates
between the TCA cycle intermediate and glutamate or aspartate (F1 and
F2), the level of anaplerosis (y), and the concentrations of each metabolite.
The input vector, UAxtyl-C.A, is governed by the fraction of 13C-enriched
acetyl-CoA entering the TCA cycle through citrate synthase (F0). The only
nonzero element in UAcetyl-C.A is the one corresponding to the labeling of
the 4-carbon position of citrate because all 13C label from the acetyl-CoA
2-carbon enters the TCA cycle through citrate synthase and results in
labeling at the 4-carbon position of citrate.
The detected signals in this model are the 2- and 4-carbon enrichment
glutamate in the vector. Acetyl-CoA enrichment (Fc) and anaplerosis to
citrate synthase ratio (y) were determined from high-resolution NMR
spectra of tissue extracts. Glutamate, aspartate, and a-ketoglutarate con-
centrations were measured by enzymatic assays. Other metabolite concen-
trations whose values are relatively stable to the changes in TCA cycle flux
were taken from literature on hearts perfused under similar substrate
conditions: citrate, 2.94 ,urmol/g dry wt; malate, 0.60; oxaloacetate, 0.04
(Randle et al., 1970; Taegtmeyer, 1983). The effect of possible variations
or errors in these pool sizes was evaluated by sensitivity analysis with a
200% change in pool sizes. The results show that changes in these pool
sizes will have minimal impact on the labeling kinetics of glutamate. TCA
cycle flux (VTCA) and flux of interconversion between TCA cycle inter-
mediates and amino acid pools (F1 and F2) were determined by nonlinear
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[2-13C] Acetate [2-13C] Butyrate
[2-13C] Acetyl-CoA
[2 or 3-13C]
Aspartate
(2 or 3-130] [4-13C]
Oxaloacetate Citrate
(2 or 3-130) Mitochondrial
Membrane
[2 or 3-130] TCA
[2 or 3-13C] [2 or 3-13C] G a[4-130]
Fumarate Succinate (2 or 3-13C)
FIGURE 1 Diagram of the TCA cycle. (A) Labeling scheme employed in dynamic '3C NMR spectroscopy. Both [2-13C]acetate and [2-13C]butyrate enter
the TCA cycle via [2-13C]acetyl-CoA. Initial sites of 13C labeling are at the 4-carbon position of citrate, a-ketoglutarate, and glutamate. Recycling of 13C
within TCA cycle results in the labeling of 2- and 3-carbons with equal probability. Note that glutamate, the NMR observable metabolite pool, is located
in the cytosol. (B) Compartments of metabolic intermediates used in TCA flux analysis. Large boxes represent metabolite pools of or related to TCA cycle.
Small boxes represent mathematical compartments of the model. Labeling of 3-carbon is the same as that of 2-carbon and is therefore omitted. Mixing of
label occurs after the a-ketoglutarate compartment. Anaplerosis and cataplerosis occur at the malate pool. The kinetic model is composed of nine differential
equations describing the labeling kinetics of nine compartments. CIT, citrate; aKG, a-ketoglutarate; GLU, glutamate; MAL, malate; OAA, oxaloacetate;
ASP, aspartate. VTCA, TCA cycle flux; F1, interconversion flux between a-ketoglutarate and glutamate; F2, interconversion flux between aspartate and
oxaloacetate. Note that F1 and F2 are not the same as flux through transaminase reactions because transport across mitochondrial membrane is also involved.
least-square fitting of the model to '3C enrichment data from NMR spectra
using the Levenberg-Marquardt method. Because alanine and pyruvate
concentrations in all four experimental groups were low, alanine amino-
transferase activity is minimal. Therefore, the interconversion rates be-
tween a-ketoglutarate and glutamate, and between oxaloacetate and aspar-
tate were set equal, i.e., F1 = F2. The optimization was performed using
MATLAB (The MathWorks, Inc., Natick, MA).
Metabolic rates
TCA cycle flux can be calculated from the rate of oxygen consumption
(MVO2) with knowledge of the substrate that is fueling respiration (Koba-
yashi and Neely, 1979; Randle et al., 1970). For example, for the oxidation
of 1 mole of acetate, 3 moles of NADH and 1 mole of FADH2 are
generated, which results in the consumption of 2 moles of oxygen. Hence,
FIGURE 2 Metabolic diagram of acetate and butyrate oxidation. Acetate
has direct entry into the TCA cycle via acetyl-CoA. Butyrate, as a four-
carbon molecule, undergoes 13-oxidation to be cleaved into two acetyl-CoA
molecules before entering the TCA cycle. a3-Oxidation generates additional
reducing equivalents that require oxygen to be reoxidized. Therefore, at the
same oxygen consumption rate, TCA cycle flux from butyrate oxidation is
slower compared to acetate oxidation, yet the energy yield is the same.
the turnover of TCA cycle is one-half of the oxygen consumption. In the
case of butyrate oxidation, because additional NADH and FADH2 are
generated in ,-oxidation, the ratio of TCA flux to MVO2 is 1:2.5 (Fig. 2).
Therefore, MVO2 provided experimental constraints of TCA cycle flux for
optimization in kinetic analysis. While the optimal value for TCA cycle
flux was obtained from least-square fitting of the model to dynamic 13C
NMR observation, a penalty function that reflects the difference between
fitted TCA cycle flux and the TCA cycle flux calculated from oxygen
consumption was added to the objective function. This allowed the com-
puter to search in a range of estimated TCA cycle flux from oxygen
consumption while taking into consideration the measurement error and the
oxidation of other fuels.
Statistical analysis
All data are presented as mean ± SD. Comparison of intragroup data sets
was performed with Student's paired, two-tailed t-test. Differences in mean
values were considered statistically significant at a probability level of less
that 5% (p < 0.05).
RESULTS
Contractile function and oxygen consumption
Contractile function, as assessed by rate pressure product
(RPP), was similar for hearts at normal workload: 17,100 ±
4,100 beats'mmHg/min for hearts oxidizing acetate, and
19,900 ± 6,400 for hearts oxidizing butyrate. Oxygen con-
sumption (MVO2) was also similar: 19.4 ± 3.7 ,umol/min/g
dry wt for the acetate group, and 18.4 ± 3.4 ,umol/min/g dry
wt for the butyrate group. Hearts arrested with KCl gener-
ated no mechanical work. As expected, their oxygen con-
sumption was significantly lower: acetate, 7.5 ± 1.4 ,umol/
min/g dry wt; butyrate, 6.9 ± 3.0 ,umol/min/g dry wt. These
results are consistent with both our previous findings
A B
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TABLE I Steady-state metabolite contents and substrate utilization
Glutamate a-Ketoglutarate Aspartate F. (%) y (%)
Acetate 29.11 ± 2.50 0.50 ± 0.35 1.56 ± 0.80 92.1 ± 6.8 8.9 ± 4.1
Butyrate 26.90 ± 5.59 0.61 ± 0.50 3.27 ± 1.49 47.7 ± 6.2 13.2 ± 4.6
Acetate + KCl 22.64 ± 6.16 0.74 ± 0.09 1.14 ± 0.24 91.9 ± 1.5 11.6 ± 0.9
Butyrate + KCI 22.53 ± 3.58 0.91 ± 0.41 0.95 ± 0.40 47.6 ± 4.9 22.1 ± 11.8
FC, fraction of 13C-enriched acetyl-CoA entering the TCA cycle. y, ratio of anaplerosis to citrate synthase activity. Values of FC and y were determined from
high-resolution NMR spectra of tissue extracts. Metabolite concentrations are measured by enzymatic assays. All values are given as mean ± SD.
Metabolite concentrations are given as ,mol/g dry tissue weight.
(Lewandowski, 1992b) and data from canine and rat hearts
reported by other investigators (Dean et al., 1990; Bittl and
Ingwall, 1985). Thus, the protocol afforded analysis of 13C
kinetics at normal and basal metabolic rates in both the
absence and presence of significant effects on the TCA
cycle flux from additional NADH and FADH2 generation
by (3-oxidation.
Metabolite content and GOT kinetics
Steady-state metabolite contents are tabulated in Table 1.
Values are in agreement with those measured by other
investigators for similar experimental conditions (Randle
et al., 1970; Taegtmeyer, 1983). There were no statistically
significant differences among all four groups. Kinetic pa-
rameters of GOT from both cytosol and mitochondria are
presented in Table 2.
13C NMR measurements
Proton-decoupled 13C spectra from tissue extracts were
similar to those previously presented (Lewandowski et al.,
1991a; Lewandowski and Hulbert, 1991; Lewandowski,
1992b). Quantitatively, spectra from KCl-arrested hearts
were similar to that of hearts oxidizing the same substrate at
normal workload. [2-13C]Butyrate induced a lower level of
doublet signal from glutamate 4-carbon resonance because
only 50% [2-12C]acetyl-CoA, at most, entered the TCA
cycle after butyrate was cleaved into two acetyl-CoA mol-
ecules by 13-oxidation. The fraction of 13C-enriched acetyl-
CoA entering the TCA cycle (Fe) and the ratio of anaple-
rotic flux to citrate synthase activity (y) calculated from
high resolution 13C NMR spectra are presented in Table 1.
As expected, Fc values from hearts oxidizing [2-13C]bu-
tyrate at both normal workload and during arrest were half
TABLE 2 Measured glutamate-oxaloacetate
transaminase activity
Cytosol Mitochondria
Vm. (gmolImin/mg total heart protein) 1.62 ± 0.02 1.06 ± 0.05
Km of a-ketoglutarate (mM) 0.12 ± 0.03 3.22 ± 0.28
Km of glutamate (mM) 10.69 ± 2.35 32.49 ± 0.98
Km of aspartate (mM) 2.72 ± 0.08 0.89 ± 0.04
Cytosolic GOT activity was measured at pH = 7.2. Mitochondrial GOT
activity was measured at pH = 7.7. All values are given as mean ± SD.
that of hearts oxidizing [2-13C]acetate because of the en-
richment difference discussed above.
Fig. 3 shows representative, sequential spectra from
hearts at normal workloads. Note that incorporation of label
into the glutamate pool with [2-13C]butyrate was signifi-
cantly delayed in reaching steady state as compared to
hearts oxidizing [2-13C]acetate. This delay is evident in Fig.
4, which shows the time course of 13C enrichment of glu-
tamate at 2- and 4-carbons from all acquired spectra along
with results from least-square fitting.
The delayed approach to steady state of glutamate label-
ing with hearts oxidizing butyrate was quantitated by the
time constants of the labeling curves from a single expo-
nential fit. The time constants for the labeling of glutamate
4- and 2-carbons are as follows: in the acetate group, 7 min
for 4-carbon, 17 min for 2-carbon; in the butyrate group, 10
min for 4-carbon, and 32 min for 2-carbon. This delay in
glutamate labeling with butyrate oxidation also appears
in KCl-arrested hearts as shown in Fig. 4, where the time
constants are: with acetate, 14 min for 4-carbon, 46 min for
2-carbon; with butyrate, 21 min for 4-carbon, 97 min
for 2-carbon. However, these time constants cannot be used
as a direct index of TCA cycle flux because two processes
are involved that can affect the labeling kinetics of gluta-
mate-one is TCA cycle activity, the other is exchange of
label between a-ketoglutarate and glutamate.
Results from kinetic analysis
Results from least-square fitting of the kinetic model to
glutamate labeling are shown in Fig. 4. In all four groups, a
precise fit of the model to the experimental data was evi-
TABLE 3 Flux rates kinetic analysis and GOT measurements
Perfusate supply VTCA F1 FGOT
Acetate 10.1 ± 0.2 9.3 ± 0.6 223
Butyrate 7.1 ± 0.2 6.4 ± 0.5 362
Acetate + KCl 3.1 ± 0.1 5.8 ± 0.6 181
Butyrate + KCl 1.8 ± 0.1 4.4 ± 1.0 158
VTCA, TCA cycle flux. F1, flux of chemical exchange between glutamate
and a-ketoglutarate. FGOT, flux through cytosolic glutamate-oxaloacetate
transaminase (GOT). VTCA and FL values are determined from kinetic
analysis of NMR data and are given as mean + SD, with the standard
deviation calculated from Jacobian matrix of the kinetic model. FGOT
values are calculated from measured kinetic parameters of GOT. All flux
values are presented as ,Lmollmin/g dry tissue weight.
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FIGURE 3 Dynamic 13C NMR spectra of isolated rabbit hearts. Spectra are from representative, isolated hearts at normal workload and were acquired
during a period of 1 (left) or 2.5 (right) min. Labeled substrates were 2.5 mM [2-13C]acetate (left) and 2.5 mM [2-13C]butyrate (right). Heart oxidizing
acetate reached steady state in 30 min. Butyrate oxidizing heart reached steady state in 50 min. Identifiable resonance peaks: GLU-C2, 2-carbon of
glutamate; GLU-C4, 4-carbon of glutamate; GLU-C3, 3-carbon of glutamate; ACE-C2, 2-carbon of acetate; BU-C2, 2-carbon of butyrate.
dent. TCA cycle flux (VTcA) and F1 were each determined
from nonlinear least-square fitting and are presented in
Table 3 with the standard deviation calculated from the
Jacobian matrix of the model. KCl-arrested hearts showed
significantly reduced TCA cycle flux, only 25-31% of that
of hearts at normal workload. On the other hand, hearts
oxidizing butyrate also have reduced TCA cycle activity as
compared with hearts oxidizing acetate, despite similar ox-
ygen consumption and workload. The result is due to the
presence of ,B-oxidation generating additional reducing
equivalents to meet energy demand at a correspondingly
lower TCA cycle flux. The exchange rate between a-keto-
glutarate and glutamate was also slightly slower in hearts
perfused with butyrate. In combination, the reduced TCA
cycle flux and the slower interconversion rate accounted for
a general delay in the observed 13C enrichment curve from
hearts oxidizing butyrate.
To test whether low Fc values can have an impact on the
rate of labeling and isotope turnover in glutamate, we also
perfused hearts with [2,4-13C]butyrate so that both acetyl-
CoA molecules generated from f3-oxidation were labeled at
the 2-carbon. 13C spectra from tissue extracts showed a
heightened doublet signal in the glutamate 4-carbon reso-
nance, resembling that of hearts perfused with [2-13C]ac-
etate. As expected, acetyl-CoA enrichment increased to
92.8%, comparable to that of hearts oxidizing acetate. Yet
anaplerosis was similar to hearts perfused with [2-13C]bu-
tyrate: y = 13.2%. Despite this high acetyl-CoA enrichment
level, the dynamics of glutamate enrichment showed little
difference from hearts oxidizing [2-13C]butyrate (Fig. 5).
Using the same flux parameters obtained from kinetic anal-
ysis of data from the [2-13C]butyrate group, our simulated
enrichment curve was in agreement with the experimental
data (Fig. 5). Therefore, the observed delay in glutamate
labeling from hearts perfused with butyrate was caused by
differences in metabolic activity rather than dilution of
label, which is consistent with previous findings (Lewan-
dowski and Hulbert, 1991).
Transaminase rates and
metabolite compartmentation
Based on measured metabolite contents (Table 1) and ki-
netic parameters of GOT (Table 2), flux through GOT
(FGOT) was calculated according to the double-displace-
ment (ping-pong) reaction kinetics and is presented in Table
3 for comparison to the chemical exchange rate between
a-ketoglutarate and glutamate, F1. Heart protein to tissue
weight ratio is 683 mg total heart protein/g dry tissue
weight, and the volume to tissue weight ratio is 2 ml/g dry
tissue weight (Idell-Wenger et al., 1978), as used for calcu-
lation of flux through GOT in Table 3. FGOT was highest in
the butyrate group because of the larger mean value for the
aspartate pool (Table 1). As shown in Table 3, the F1
determined from least-square fitting of the model was at
least 20 times slower than FGOT in all four groups. F1 was
comparable to TCA cycle flux in hearts at normal workload
and was twice the TCA cycle flux in KCl-arrested hearts.
Data fitting was also performed in the absence of the
constraint provided by measured oxygen consumption. Re-
moving this constraint allows a 9% deviation in TCA cycle
flux and a 14% deviation in F1 from the values obtained
l~~~~~~
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FIGURE 4 Time course of glutamate 13C enrichment from both NMR measurement and kinetic analysis. Signal intensities from dynamic 13C NMR
spectra are normalized to steady-state enrichment levels of the 4-carbon of glutamate. NMR data are shown in squares. E, 13C enrichment level of glutamate
at 4-carbon position; C], 13C enrichment level of glutamate at 2-carbon position. Solid lines are modeled enrichment curves from least-square fitting. (A) 2.5
mM [2-13C]acetate; (B) 2.5 mM [2-13C]butyrate; (C) 2.5 mM [2-13C]acetate + 20 mM KCI; (D) 2.5 mM [2-13C]butyrate + 20 mM KCI.
from the full model. Even under these unregulated experi-
mental conditions, F1 remained on the order of TCA cycle
flux, significantly lower than the determined GOT flux rate.
We also used a fixed TCA cycle flux, calculated from the
lower limits of oxygen consumption, so that only F1 was
then fitted to the model, yielding increased F1 for each
group. However, these F1 values remained an order of
magnitude lower than GOT flux. If FGOT alone is used to
represent the isotope exchange rate, then simulated enrich-
ment curves showed poor agreement with experimental
data. The results of this test are shown in Fig. 6. Therefore,
flux through GOT is not the rate-limiting step in the ex-
change between a-ketoglutarate and glutamate. This slow
exchange rate might be a result of metabolite transport due
to metabolite compartmentalization, as the TCA cycle en-
zymes are intramitochondrial and over 90% of glutamate is
cytosolic.
Considerations of the model
In our model, 13C label entering the TCA cycle from the
acetyl-CoA pool is treated as a step function, i.e., acetyl-
CoA is instantly enriched to the level of Fc upon the
delivery of 13C enriched substrate. Actually, the time course
of acetyl-CoA enrichment occurs as an exponential function
of time, where the time constant is the ratio of acetyl-CoA
concentration to the flux through the TCA cycle. Because
physiological concentrations of acetyl-CoA are approxi-
mately 0.2 ,umol/g dry wt (Peuhkurinen and Hassinen,
1982), the time constant for the enrichment of acetyl-CoA is
very small, from 0.02 to 0.11 min. The enrichment level of
acetyl-CoA 10 s after delivery of labeled substrate is already
78% of steady-state values, and by 30 s it is 99%. Thus, the
assumption of instant equilibration of acetyl-CoA is a rea-
sonable approximation.
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FIGURE 5 Glutamate 13C enrichment from heart oxidizing [2,4-'3C]bu-
tyrate. Open and closed squares are NMR measured 13C enrichment levels
of 2- and 4-carbons of glutamate from hearts perfused with [2,4-13C]bu-
tyrate (n = 2). Solid lines are simulated enrichment curves made by using
the same flux parameters obtained from kinetic analysis of [2-13C]butyrate
data presented in Table 3. The good agreement between simulated curves
and experimental data is demonstrated.
Measurements of the TCA cycle intermediates that are
at very low concentrations, a-ketoglutarate, malate, and
oxaloacetate, are subject to great statistical fluctuations.
To test the robustness of the model to such measurement
errors, sensitivity analysis was performed by perturbing
the pool size of these compartments by threefold. Fig. 7
shows the simulated time course of glutamate enrichment
for measured pool size (solid lines), increased pool size
(dotted lines), and decreased pool size (dashed lines).
The results, as shown, demonstrate that even the most
dramatic changes in pool sizes had little impact on the
dynamics of glutamate 13C enrichment. Therefore, pre-
1
FIGURE 6 Difference between en-
zyme rate and interconversion rate. The
flux through glutamate-oxaloacetate
transaminase (GOT), calculated from
measured Vmax and Km of GOT as the
exchange rate between ca-ketoglutarate
and glutamate, was used to create the
simulated time course of glutamate 13C
enrichment (---- ), which shows very
poor agreement with the experimental
data (squares, acetate group). *, mea-
sured 13C enrichment level of gluta-
mate at 4-carbon; Z, 13C enrichment
level of glutamate at 2-carbon.
simulated time course of glutamate 13C
enrichment using flux parameters de-
termined from kinetic analysis (acetate
group).
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FIGURE 7 Sensitivity analysis. Simulated time course of glutamate en-
richment with a simultaneous threefold increase (--- - -) or decrease (- --)
in ca-ketoglutarate, malate, and oxaloacetate levels showed little difference
from that of measured pool size ( ). The minor impact of TCA
intermediates on glutamate enrichment demonstrates the robustness of
estimated parameters when measurements of TCA cycle intermediates are
subject to large statistical fluctuations.
steady-state labeling of glutamate is insensitive to
changes in a-ketoglutarate, malate, and oxaloacetate at
physiological levels.
Our current model is derived from simplified compart-
mentation of the TCA cycle by eliminating non-rate-
limiting pools. To justify this simplification, we have
compared simulation results of our reduced model with
that of a more comprehensive model that also includes
succinate and fumarate pools along with equations to
describe both 2- and 3-carbon labeling (8 compartments,
19 differential equations). These two models showed no
difference in characterizing the 13C labeling kinetics of
glutamate. A closer look at the fractional enrichment of
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succinate, malate, and fumarate as a function of time
shows that the downstream compartment follows the
labeling pattern of the previous compartment very
closely. This similarity in labeling dynamics of the TCA
cycle intermediates is perhaps induced by a relatively
large TCA cycle flux as compared to the concentrations
of TCA cycle intermediates, which are usually on the
order of less than 1 ,umol/g dry wt.
DISCUSSION
In this study, changes in oxidative metabolism were studied
by 13C NMR spectroscopy at different workload demands
and metabolic rates. The influence of the differences in both
metabolic rate and control of the turnover of the 13C label
within the NMR detectable glutamate pool were systemat-
ically examined. Dynamic 13C spectra, reflecting the evo-
lution of enrichment in the glutamate pool, were acquired
with 1- or 2-min temporal resolution from intact, function-
ing hearts. Oxygen consumption and mechanical perfor-
mance in response to distinctly different physiological de-
mands and metabolic regulation were constantly monitored
during the acquisition ofNMR spectra. Data acquired in this
mode were analyzed with a kinetic model to determine
metabolic fluxes and rate-limiting steps. The model for
isotope enrichment was tested for sensitivity to metabolite
content, respiratory rate, and transaminase activity from
four experimental groups. Measured physiological con-
straints provided the experimental range of data fitting. The
model integrates data from enzymatic assays, high-resolu-
tion 13C NMR data from tissue extracts, and dynamic
changes in 13C NMR spectra from intact hearts to evaluate
metabolic regulation in functioning organs. From this study,
both TCA cycle flux and the interconversion rate between
metabolite pools were determined from the evolution of 13C
NMR signals from intact hearts for comparison to experi-
mentally measured enzyme kinetics.
Several previous studies have employed modeling
schemes to explore TCA cycle flux and its regulation. These
have been based on changes of 14C activity of intermediates
(Randle et al., 1970; Nuutinen et al., 1981), tissue clearance
of '1C label from PET study (Ng et al., 1994), or 13C
enrichment over time of tissue glutamate (Chance et al.,
1983; Fitzpatrick et al., 1990; Mason et al., 1992; Weiss
et al., 1992; Robitaille et al., 1993b). Our current efforts
were not focused toward improving upon existing models of
isotope turnover, but rather toward applying a simple model
that incorporates a larger number of measured constraints
for accurately predicting only the two variables of interest in
this study, VTCA and F1.
Our simplified model is a modification of that developed
by Chance et al. (Chance et al., 1983). By considering the
total labeling of carbons at 2-, 3-, and 4-carbons instead of
individual isotopomer, we were able to take the advantage
of the symmetry in isotope labeling at the 2- and 3-carbon
ber of equations necessary to represent the entire model.
Consequently, only nine differential equations were needed
in representing the kinetics of isotope turnover within the
glutamate pool. Sensitivity analysis was also performed to
test the robustness of the model to changes in TCA cycle
intermediates. By incorporating data from the analysis of
high-resolution 13C spectra of heart extracts, anaplerosis
and substrate utilization were also accounted for in kinetic
analysis, leaving only two parameters to be fitted from the
model. Therefore, this model has the advantage of being
simple in its formality and yet including as much biolog-
ical information as possible with a minimal number of
adjustable unknowns. This simple model should also be
readily applicable to in vivo conditions, provided that
constraint parameters are available from appropriate in
vivo monitoring and a priori knowledge of metabolite
pool sizes.
Oxidative metabolic activity in response to various work-
loads has been previously investigated by 13C NMR spec-
troscopy, and delayed incorporation of 13C label into the
glutamate pool for hearts at lower workload or basal meta-
bolic state was reported (Lewandowski, 1992b; Weiss et al.,
1992). In this study, in addition to changed workload con-
ditions, substrates with different metabolic pathways (13-
oxidation versus no ,3-oxidation) were used to investigate
the effect of metabolic control on the kinetics of glutamate
enrichment. Hearts oxidizing butyrate showed contractile
performance similar to that of hearts oxidizing acetate. The
oxygen consumption rate was also similar. When partial
labeling of acetyl-CoA from [2-13C]butyrate oxidation was
accounted for, the utilization of exogenous substrate for
both substrates was also similar. Despite all of these simi-
larities, the time course of 13C enrichment in the glutamate
pool for hearts oxidizing butyrate showed a significantly
delayed approach to the steady state in both normal and
KCl-arrested hearts. When [2,4-13C]butyrate was used as
the substrate, the fraction of 13C-enriched acetyl-CoA
reached the same level as hearts oxidizing [2-13C]acetate,
yet kinetics of glutamate enrichment remained unchanged.
Because of the additional reducing equivalents generated in
13-oxidation, hearts perfused with butyrate had a slower
TCA cycle flux than hearts oxidizing acetate at the same
respiratory rate. In addition, the interconversion rate be-
tween a-ketoglutarate and glutamate determined from ki-
netic analysis was also slightly slower with hearts perfused
with butyrate. The reduced TCA cycle flux and intercon-
version rate gave rise to the delayed incorporation of label
into the glutamate pool observed in hearts perfused with
butyrate.
Substrate utilization and relative flux of anaplerosis were
also determined from high-resolution NMR spectra of tissue
extracts in this study. Whereas substrate utilization was
found to be the same for both short-chain fatty acids re-
gardless of working conditions, the ratio of anaplerosis to
citrate synthase activity (y) increased slightly when butyrate
was used as the substrate (Table 1). However, care must be
positions of the metabolic intermediates to reduce the num-
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contribution of anaplerosis to TCA cycle activity. Although
y increased slightly when butyrate was supplied, the calcu-
lated anaplerotic flux (y X VTCA) was similar to that of
hearts oxidizing acetate at the same working condition:
acetate, 0.90 ,umol/min/g dry tissue weight; butyrate,
0.94; acetate with KCl, 0.36; butyrate with KCl, 0.40.
Therefore, hearts at basal metabolic state may have a
relatively lower anaplerotic flux because of a lower en-
ergy requirement.
An important consideration is that earlier applications of
13C dynamics have not included potential rate-limiting steps
beyond that of TCA cycle flux (Chance et al., 1983;
Fitzpatrick et al., 1990; Mason et al., 1992). Although a
potential effect of the transaminase rate on glutamate label-
ing has been experimentally demonstrated by Weiss, et al.
with a transaminase inhibitor (Weiss et al., 1995), the phys-
ical compartmentation of the glutamate and TCA cycle
intermediates must also be considered. This is important
because the GOT enzyme is not allosterically regulated and
the reaction rate is governed by the specific activity of the
enzyme in the myocardium and the concentrations of the re-
actants in the tissue. Indeed, our characterization of the
glutamate-oxaloacetate transaminase kinetics shows the re-
action rate of the transaminase to be at least 20 times higher
than the TCA cycle turnover (Table 3). However, kinetic
analysis of glutamate labeling of intact hearts has suggested
a significantly slower exchange rate between a-ketoglut-
arate and glutamate. It is on the order of TCA cycle flux in
all four experimental groups. Because most of the tissue
glutamate is located in the cytosol whereas the TCA cycle
enzymes are located in mitochondria, there is membrane
transport involved in addition to chemical exchange. There-
fore, the findings of this study suggest that the slower
exchange rate found in intact hearts is due to transport of
a-ketoglutarate across the mitochondrial membrane.
If the exchange of label between a-ketoglutarate and
glutamate is rate limiting, then the rate of isotope enrich-
ment of glutamate will not precisely reflect rates of isotope
incorporation into the TCA cycle intermediates. Fig. 8 A
shows the simulated time course of 13C enrichment for both
glutamate and a-ketoglutarate by using flux parameters
determined from the acetate group. It is obvious that pre-
steady-state enrichment of glutamate has a significant delay
as compared to the enrichment of a-ketoglutarate. Although
only the group of hearts oxidizing acetate at normal work-
load is shown, the other three groups showed similar delay
in glutamate enrichment. Furthermore, because a-ketoglu-
tarate is in constant chemical exchange with glutamate, its
labeling kinetics is ultimately determined by both TCA
cycle flux and the exchange rate between glutamate and
a-ketoglutarate. Therefore, even the enrichment of a-keto-
glutarate cannot be simply regarded as an index of the TCA
cycle. As can be seen from Fig. 8 B, the time course of
a-ketoglutarate enrichment is very different from that of ci-
trate, in which enrichment is determined solely by TCA
cycle flux.
Evidence that glutamate is largely cytosolic is as follows.
Transport of glutamate into heart mitochondria occurs al-
most exclusively via the glutamate/aspartate exchange
transporter (LaNoue and Schoolwerth, 1979; Tischler et al.,
1976). Thus, the total of glutamate plus aspartate content in
mitochondria is constant at approximately 12 nmol/mg mi-
tochondrial protein (LaNoue et al., 1970), or 3.6 ,mol/g dry
heart weight. This is the maximum number for mitochon-
drial glutamate, whereas the total is 22-29 ,umol/g dry heart
weight. Thus, a very large fraction of the glutamate pool is
located in the cytosol, and NMR detection of isotope ex-
change between glutamate and a-ketoglutarate relies on the
efflux of a-ketoglutarate from the mitochondria to the cy-
tosol. The efflux of a-ketoglutarate is accompanied by
A 1
FIGURE 8 Simulated time course
of 13C enrichment of citrate, a-keto-
glutarate, and glutamate. Flux param-
eters are determined from least-
square fitting of the kinetic model to
NMR data in hearts oxidizing
[2-13C]acetate at normal workload.
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ics between glutamate ( ) and
a-ketoglutarate ---- ) (A), and be-
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malate influx through an electroneutral malate-a-ketoglu-
tarate antiport carrier in the malate-aspartate shuttle system
(Safer, 1975).
The interaction of the malate-aspartate shuttle with the
TCA cycle provides a likely mechanism for the commu-
nication and coordination between mitochondrial and cy-
tosolic metabolism (LaNoue and Williamson, 1971). The
relatively slow interconversion rate that was observed in
the current set of experiments could be due to the influ-
ence of the malate-aspartate shuttle, which transports
several of the intermediates involved in the exchange of
label. The process may be further influenced by shifts in
the balance of these intermediates in response to changes
in intracellular redox state (Lewandowski et al., 1995).
Although the involvement of malate-aspartate shuttle in
the exchange of label between glutamate and a-keto-
glutarate is appreciated by some investigators (Robitaille
et al., 1993b; Chatham et al., 1995), this study represents
the first experimental evidence that this process is an-
other rate-limiting step in determining the enrichment
rate of glutamate. Thus, dynamic observations of intact
tissues with 13C NMR spectroscopy offer the opportunity
to explore metabolic regulation at the level of both TCA
cycle flux and the communication between intra- and
extramitochondrial compartments.
We have used metabolite contents in the whole cell as
our pool sizes in the kinetic model, making the tacit
assumption that the gradients of these metabolites across
the mitochondrial membrane are not large. Distribution
of metabolites between the mitochondria and cytosol has
been measured in perfused livers (Soboll et al., 1980) by
using techniques that are difficult to apply to myocytes.
These direct measurements in fact have never been made
on heart tissue. However, conclusions can be drawn
about the size of these metabolite gradients from studies
of isolated mitochondria where the mitochondria have
been rapidly separated from media for analysis (LaNoue
et al., 1973), or where the NMR signal of metabolites
inside the mitochondria can be distinguished from NMR
signals of the external metabolites (Masiakos et al., 1991;
Hutson et al., 1992). From these studies, the mitochon-
drial gradient of TCA cycle intermediates and glutamate
and aspartate can be considered to be lower in heart than
in liver. In the liver, a proton-linked, glutamate trans-
porter permits the formation of a glutamate gradient that
is proportional to a pH gradient. The activity of this
transportor is very low in heart, to the extent that gluta-
mate influx into the mitochondria is determined by ex-
change of glutamate for aspartate. In liver, a transporter
exchanges dicarboxylic acids for phosphate across a
phosphate gradient that is supported by a pH gradient
(Masiakos et al., 1991; Hutson et al., 1992). However, the
activity of the phosphate/dicarboxylate in heart is very
low and TCA cycle intermediates cross the mitochondrial
membrane only via exchange with each other. Therefore,
our assumption that the total intermediate pools can be
Because glutamate and aspartate can be both mito-
chondrial and cytosolic, the interconversion rate between
glutamate and a-ketoglutarate is really a lumped factor
that involves both transaminase flux and transport rate. In
the calculation of transaminase flux, because of the small
mitochondrial space compared to cytosolic space and
consistency of the mitochondrial glutamate plus aspartate
pool, the majority of the metabolites are located in the
cytosol. Data from isolated mitochondria suggest that
mitochondrial content of glutamate and aspartate is ap-
proximately 12 nmol/mg mitochondrial protein (LaNoue
et al., 1970), aspartate alone is 1 nmol/mg (LaNoue et al.,
1974), and a-ketoglutarate is 0.4 nmol/mg (LaNoue
et al., 1973). This implies that 88% of the aspartate and
85% of the a-ketoglutarate are located in the cytosol. If
correction is made according to these values, the calcu-
lated transaminase flux in the acetate group would be 202
,umol/min/g dry tissue. This difference is within 10% in
all four experimental groups. However, the correction
introduced no change to the simulated enrichment curves
in Fig. 6 (dotted lines) and therefore still cannot account
for the significantly slower interconversion rate deter-
mined from kinetic analysis.
In summary, sequential 13C NMR spectra were ob-
tained from intact hearts at either normal workload or
basal metabolic state during perfusion with either 13C-
enriched acetate or butyrate. A kinetic model was devel-
oped for the analysis of 13C enrichment data to evaluate
the regulations in oxidative metabolism and to detect
rate-limiting steps in glutamate enrichment. From this
analysis, the interconversion between glutamate and
a-ketoglutarate was found to be slow relative to the
transaminase rate from measured enzyme kinetics. Thus,
the exchange of the glutamate pool with TCA cycle
intermediates is influenced by rate-limiting processes
beyond mere chemical exchange across enzymatic reac-
tions. The implication of these results is that 13C NMR is
sensitive not only to TCA cycle activity but also to
transport processes for isotope exchange across the mi-
tochondrial membrane. We believe this finding provides
a valuable new tool in 13C NMR for monitoring a sub-
cellular process that previously could only be studied in
isolated mitochondria.
APPENDIX
The mathematical model used for kinetic analysis is derived from a
simplified compartment model of the TCA cycle, including the follow-
ing key metabolite pools: citrate, a-ketoglutarate, malate, oxaloacetate,
glutamate, and aspartate (Fig. 1 B). Instead of taking each isotopomer
as a single compartment as proposed by Chance et al. (1983), this model
is based on a series of compartments including only the total labeling of
'3C at either the 2-, 3-, or 4-carbon positions of each metabolite as
individual compartments. A further simplification was made by elimi-
nating those equations describing the enrichment of 3-carbon due to the
symmetry of 2- and 3-carbon labeling. Therefore, the model has nine
compartments in total, as shown in small boxes in Fig. 1 B. By the
principle of mass conservation, the labeling history of the metabolites
used as estimates of cytosolic fractions is validated.
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can be characterized by a group of nine differential equations incorpo-
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rating both TCA cycle flux and interconversion rates between metab-
olite pools:
d CIT4 = VTCA (FC- CIT4)dt [CIT]
d VTCA
- aKG4 CTdt [aKG] CIT4
VTCA + F, F1K aKG4 + [ -] GLU4[aKG] [aKG]
d F1
GLU4 = , (aKG4 - GLU4)dt [GLU]
d VTCA
- CIT2 = *(OAA2-CIT2)dt [CIT]
d VTCA
- aKG2 = CIT2dt [aKG]
VTCA + F2 F*
[K]aKG2 + GLU2[aKG] ~ [aKG]
d F1
- GLU2 = [ *(aKG2 - GLU2)dt [GLU]
d VTCA
- MIAL2 =dt ~ [MAL]
_[1 1
H*[aKG2+LOaKG4-AS+yd MAL2
d
OAA2= VTA_ MAL2dt [OAA]
VTCA + F2 F2
OAA2+ ASP2[OAA] [OAA]
d F2
-ASP2= (OAA2
-ASP2)dt [ASP]
Here, CIT, aKG, GLU, MAL, OAA, and ASP denote the metabolites
citrate, ca-ketoglutarate, glutamate, malate, oxaloacetate, and aspartate,
respectively. [CM, [aKG], [GLUJ, [MAL], [OAA], and [ASP] are the
total pool sizes of the corresponding metabolites. XXXn is the dimension-
less fractional enrichment level of 13C of certain metabolite at the nth
carbon position. For example, CIT4 is the fractional enrichment level of
13C at the 4-carbon position of citrate, i.e.,
[{4 - 13C}CIT]
CIT4 = [CIT]
VTCA is the TCA cycle flux. F1 and F2 are the fluxes of interconversion,
including both transamination and membrane transport, between a-keto-
glutarate and glutamate, and between aspartate and oxaloacetate respec-
tively. Pool sizes are expressed as ,umol/g dry wt, and flux values are in
,Lmol/min/g dry wt.
This work was supported by National Heart, Lung, and Blood Institute
grant R01HL49244 (E.D.L.) and was done during the tenure of an Estab-
lished Investigator Award from the American Heart Association to E.D.L.
REFERENCES
Bailey, I. A., D. G. Gardian, P. M. Matthews, G. K. Radda, and P. J.
Seeley. 1981. Studies of metabolism in the isolated, perfused rat heart
using 13C NMR. FEBS Leu. 123:315-318.
Bergmeyer, H. U. 1974. Methods of Enzymatic Analysis. Academic Press,
New York.
Berkich, D. A., G. D. Williams, P. T. Masiakos, M. B. Smith, P. D. Boyer,
and K. F. LaNoue. 1991. Rates of various reactions catalyzed by ATP
synthase as related to the mechanism of ATP synthesis. J. BioL Chem.
266:123-129.
Bittl, J. A., and J. S. Ingwall. 1985. Reaction rates of creatine kinase and
ATP synthesis in the isolated rat heart: a 31p NMR magnetization
transfer study. J. Bio. Chem. 260:3512-3517.
Chacon, E., J. M. Reece, A.-L. Nieminen, G. Zahrebelski, B. Herman, and
J. J. Lemasters. 1994. Distribution of electrical potential, pH, free Ca2 ,
and volume inside cultured adult rabbit cardiac myocytes during chem-
ical hypoxia: a multiparameter digitized confocal microscopic study.
Biophys. J. 66:942-952.
Chance, E. M., S. H. Seeholzer, K. Kobayashi, and J. R. Williamson. 1983.
Mathematical analysis of isotope labeling in the citric acid cycle with
applications to 13C NMR studies in perfused rat hearts. J. Bio. Chem.
258:13785-13794.
Chatham, J. C., J. R. Forder, J. D. Glickson, and E. M. Chance. 1995.
Calculation of absolute metabolic flux and the elucidation of the path-
ways of glutamate labeling in perfused rat heart by 13C NMR spectros-
copy and nonlinear least squares analysis. J. Biol. Chem. 270:
7999-8008.
Dean, E. N., M. Shalafer, and J. M. Nicklas. 1990. The oxygen consump-
tion paradox of "stunned myocardium" in dogs. Basic Res. Cardiol.
85:120-131.
Fahien, L. A., and M. Strmecki. 1969a. Studies of gluconeogenic mito-
chondrial enzymes. II. The conversion of a-ketoglutarate by bovine liver
mitochondrial glutamate dehydrogenase and glutamate-oxaloacetate
transaminase. Arch. Biochem. Biophys. 130:456-467.
Fahien, L. A., and M. Strmecki. 1969b. Studies of gluconeogenic mito-
chondrial enzymes. III. The conversion of a-ketoglutarate to glutamate
by bovine liver mitochondrial glutamate dehydrogenase and glutamate-
oxaloacetate transaminase. Arch. Biochem. Biophys. 130:468-477.
Fitzpatrick, S. M., H. P. Hetherington, K. L. Behar, and R. G. Shulman.
1990. The flux from glucose to glutamate in the rat brain in vivo as
determined by 'H-observed, 13C-edited NMR spectroscopy. J. Cereb.
Blood Flow Metab. 10:170-179.
Hutson S. M., G. D. Williams, D. A. Berkich, K. F. LaNoue, and R. W.
Briggs. 1992. A 31P NMR study of mitochondrial inorganic phosphate
visibility effects of Ca++, Mn++, and the pH gradient. Biochemistry.
31:1322-1330.
Idell-Wenger, J. A., L. W. Grotyohann, and J. R. Neely. 1978. Coenzyme
A and carnitine distribution in normal and ischemic hearts. J. Biol.
Chem. 253:4310-4318.
Kelleher, J. A. 1985. Analysis of tricarboxylic acid cycle using [14C] citrate
specific activity ratios. Am. J. Physiol. 248:E252-E260.
Kobayashi, K., and J. R. Neely. 1979. Control of maximum rates of
glycolysis in rat cardiac muscle. Circ. Res. 44:166-175.
Kornberg, H. L. 1966. Anaplerotic sequences and their role in metabolism.
In Essays in Biochemistry. P. N. Campbell and G. D. Greville, editors.
Academic Press, New York. 1-31
LaNoue K. F., J. Bryla, and D. J. P. Bassett. 1974. Energy-driven aspartate
efflux from heart and liver mitochondria. J. Biol. Chem. 249:
7514-7521.
LaNoue, K. F., W. J. Nicklas, and J. R. Williamson. 1970. Control of citric
acid cycle activity in rat heart mitochondria. J. Biol. Chem. 245:
102-111.
LaNoue, K. F., and A. C. Schoolwerth. 1979. Metabolite transport in
mitochondria. Annu. Rev. Biochem. 48:871-922.
LaNoue, K. F., E. I. Walajtys, and J. R. Williamson. 1973. Regulation of
glutamate metabolism and interactions with the citric acid cycle in rat
heart mitochondria. J. Biol. Chem. 248:7171-7183.
LaNoue, K F., and J. R. Williamson. 1971. Interrelationships between
malate-aspartate shuttle and citric acid cycle in rat heart mitochondria.
Metabolism. 20:119-140.
2102 Biophysical Journal Volume 69 November 1995
Lewandowski, E. D., and D. L. Johnston. 1990. Reduced substrate oxida-
tion in postischemic myocardium: 13C and 31P NMR analyses. Am. J.
Physiol. 258:H1357-H1365.
Lewandowski, E. D. 1992a. Metabolic heterogeneity of carbon substrate
utilization in mammalian heart: NMR determination of mitochondrial
versus cytosolic compartmentation. Biochemistry. 31:8916-8923.
Lewandowski, E. D. 1992b. Nuclear magnetic resonance evaluation of
metabolic and respiratory support of work load in intact rabbit hearts.
Circ. Res. 70:576-582.
Lewandowski, E. D., M. Chari, R. Roberts, and D. Johnston. 1991a. NMR
studies of /3-oxidation and short chain fatty acid metabolism in support-
ing improved contractile recovery of reperfused myocardium. Am. J.
Physiol. 261:H354-H363.
Lewandowski, E. D., L. A. Damico, L. T. White, and X. Yu. 1995. Cardiac
responses to induced lactate oxidation: NMR analysis of metabolic
equilibria. Am. J. Physiol. In press.
Lewandowski, E. D., and C. Hulbert. 1991. Dynamic changes in 13C NMR
spectra of intact hearts under conditions of varied metabolic enrichment.
Magn. Reson. Med. 19:186-190.
Lewandowski, E. D., D. Johnston, and R. Roberts. 1991b. Effects of
inosine on glycolysis and contracture during myocardial ischemia. Circ.
Res. 68:578-587.
Malloy, C. R., A. D. Sherry, and F. M. Jeffrey. 1987. Carbon flux through
citric acid cycle pathways in perfused heart by 13C NMR spectroscopy.
FEBS Lett. 212:58-62.
Malloy, C. R., A. D. Sherry, and F. M. H. Jeffrey. 1988. Evaluation of
carbon flux and substrate selection through alternate pathways involving
the citric acid cycle of the heart by 13C NMR spectroscopy. J. Biol.
Chem. 263:6964-6971.
Masiakos, P. T., G. D. Williams, D. A. Berkich, M. B. Smith, and K. F.
LaNoue. 1991. 31P NMR saturation transfer study of the in situ kinetics
of the mitochondrial adenine nucleotide translocase. Biochemistry. 30:
8351-8357.
Mason, G. F., D. L. Rothman, K. L. Behar, and R. G. Shulman. 1992. NMR
determination of the TCA cycle rate and a-ketoglutarate/glutamate
exchange rate in rat brain. J. Cereb. Blood Flow Metab. 12:434-447.
Michuda, C. M., and M. Martinez-Carrion. 1970. The isozymes of gluta-
mate-aspartate transaminase: mechanism of inhibition by dicarboxylic
acids. J. Biol. Chem. 245:262-269.
Neely, J., H. Liebermeister, E. Battersby, and H. Morgan. 1967. Effect of
pressure development on oxygen consumption by isolated rat heart. Am.
J. Physiol. 212:804-814.
Ng, C. K., S.-C. Huang, H. R. Schelbert, and D. B. Buxton. 1994.
Validation of a model for [1-11C] acetate as a tracer of cardiac oxidation
metabolism. Am. J. Physiol. 266:H1304-H1315.
Nuutinen, E. M., K. J. Peuhkurinen, E. P. Pietilainen, J. K. Hiltunen, and
I. E. Hassinen. 1981. Elimination and replenishment of tricarboxylic
acid-cycle intermediates in myocardium. Biochem. J. 194:867-875.
Peuhkurinen, K. J. 1984. Regulation of the tricarboxylic acid cycle pool
size in heart muscle. J. Mol. Cell Cardiol. 16:487-495.
Peuhkurinen, K. J., and I. E. Hassinen. 1982. Pyruvate carboxylation as an
anaplerotic mechanism in the isolated perfused rat heart. Biochem. J.
202:67-76.
Randle, P. J., P. J. England, and R. M. Denton. 1970. Control of the
tricarboxylate cycle and its interactions with glycolysis during acetate
utilization in rat heart. Biochem. J. 117:677-695.
Robitaille, P.-M. L., D. P. Rath, A. M. Abduljalil, J. M. O'Donnell, Z.
Jiang, H. Zhang, and R. L. Hamlin. 1993a. Dynamic 13C NMR analysis
of oxidative metabolism in the in vivo canine myocardium. J. Bio.
Chem. 268:26296-26301.
Robitaille, P.-M. L., D. P. Rath, T. E. Skinner, and A. M. Abduljalil.
1993b. Transaminase reaction rates, transport activities and TCA cycle
analysis by post-steady state 13C NMR. Magn. Reson. Med. 30:262-266.
Russell, R. R., and H. Taegtmeyer. 1991. Changes in citric acid cycle flux
and anaplerosis antedate the functional decline in isolated rat hearts
utilizing acetoacetate. J. Clin. Invest. 87:384-390.
Safer, B. 1975. The metabolic significance of the malate-aspartate cycle in
heart. Circ. Res. 37:527-533.
Sherry, A. D., B. Sumegi, B. Miller, G. L. Cottam, S. Gawa, J. G. Jones,
and C. R. Malloy. 1994. Orientation-conserved transfer of symmetric
Krebs cycle intermediates in mammalian tissue. Biochemistry. 33:
6268-6275.
Soboll S., R. Elbers, R. Scholz, and H. W. Heldt. 1980. Subcellular
distribution of di- and tricarboxylates and pH gradients in perfused rat
liver. Hoppe-Seylers Z. Physiol. Chemie. 361:69-76.
Strisower, E. H., G. D. Kohler, and I. L. Chaikoff. 1952. Incorporation of
acetate carbon into glucose by liver slices from normal and alloxan-
diabetic rats. J. Biol. Chem. 198:115-126.
Taegtmeyer, H. 1983. On the inability of ketone bodies to serve as the only
energy providing substrate for rat heart at physiological work load. Basic
Res. Cardiol. 78:435-450.
Tischler, M., J., Pachence, J. R. Williamson, and K. F. LaNoue. 1976.
Mechanism of glutamate-aspartate translocation across the mitochon-
drial membrane. Arch. Biochem. Biophys. 173:448-461.
Weinman, E. O., E. H. Strisower, and I. L. Chaikoff. 1957. Conversion of
fatty acids to carbohydrate: application of isotopes to this problem and
role of the Krebs cycle as a synthetic pathway. Physiol. Rev. 37:
252-272.
Weiss, R. G., S. T. Gloth, R. Kalil-Filho, V. P. Chacko, M. D. Stem, and
G. Gerstenblith. 1992. Indexing tricarboxylic acid cycle flux in intact
hearts by carbon-13 nuclear magnetic resonance. Circ. Res. 70:392-408.
Weiss, R. G., M. D. Stem, C. P. de Albuquerque, K. Vandegaer, V. P.
Chacko, and G. Gerstenblith. 1995. Consequences of altered aspartate
aminotransferase activity on 13C-glutamate labelling by the tricarboxylic
acid cycle in intact rat hearts. Biochim. Biophys. Acta. 1243:543-548.
Williamson, J. R., and B. E. Corkey. 1969. Assays of intermediates of the
citric acid cycle and related compounds by fluorometric enzyme meth-
ods. In Methods in Enzymology. J. M. Colowick, editor. Academic
Press, New York. 434-514.
